Companies must create a risk-based framework for developing and manufacturing drugs, and acquire the scientific knowledge and technological skills to create more complex products.
Heather E. Fraser
Advertisement
Heather E. Fraser is the global lead in life sciences and pharmaceuticals at the IBM Institute for Business Value.
Articles by Heather E. Fraser
Advertisement
Latest Updated Articles
From Quality by Inspection to Quality by Design: A Roadmap for SuccessPublished: September 1st 2006 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
